Related Experiment Video
Updated: Aug 26, 2025

08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
2.7K
Breakdown of the central synapses in C9orf72-linked ALS/FTD
Layla T Ghaffari1, Davide Trotti1, Aaron R Haeusler1
1Jefferson Weinberg ALS Center, Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, United States.
Frontiers in Molecular Neuroscience
|October 3, 2022
Summary
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share genetic origins, with C9ORF72 repeat expansions causing synaptic dysfunction. This dysfunction is an early event in these progressive neurodegenerative diseases.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons, with limited treatment options.
- Cortical hyper-excitability is an early, pre-symptomatic feature of ALS, preceding motor neuron degeneration.
- The C9ORF72 gene mutation, a repeat expansion (GGGGCC)n, links ALS and frontotemporal dementia (FTD) as a disease spectrum.
Purpose of the Study:
- To review synaptic dysfunctions in the central nervous system associated with the C9ORF72 repeat expansion.
- To explore the role of C9ORF72 in maintaining synaptic physiology.
- To understand how C9ORF72 mutations contribute to ALS and FTD pathogenesis.
Main Methods:
- Literature review of studies on C9ORF72 repeat expansion in ALS and FTD.
- Analysis of findings from patient data, organismal models, and cellular models.
- Synthesis of evidence regarding synaptic dysfunction mechanisms.
Main Results:
- The C9ORF72 repeat expansion is linked to synaptic dysfunction in both ALS and FTD.
- Synaptic dysfunction occurs early in the disease process and is a common feature.
- C9ORF72 gene products appear critical for normal synaptic function.
Conclusions:
- Synaptic dysfunction is a key pathological mechanism in C9ORF72-associated ALS and FTD.
- Targeting synaptic pathways may offer therapeutic strategies for these diseases.
- Further research into C9ORF72's synaptic roles is crucial for understanding ALS/FTD spectrum disorders.
Related Concept Videos
Amyloid Fibrils
9.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.7K
Alzheimer's Disease: Overview
635
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
635

